Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions

N Franklin Adkinson,1 William E Strauss,2 Kristine Bernard,2 Robert F Kaper,2 Iain C Macdougall,3 Julie S Krop2 1Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA; 2AMAG Pharmaceuticals, Inc., Waltham, MA, USA; 3Depar...

Full description

Bibliographic Details
Main Authors: Adkinson NF, Strauss WE, Bernard K, Kaper RF, Macdougall IC, Krop JS
Format: Article
Language:English
Published: Dove Medical Press 2017-09-01
Series:Journal of Blood Medicine
Subjects:
anaphylaxis
ferric carboxymaltose
ferumoxytol
hypersensitivity
hypotension
iron deficiency anemia
Online Access:https://www.dovepress.com/comparative-safety-of-intravenous-ferumoxytol-versus-ferric-carboxymal-peer-reviewed-article-JBM

Internet

https://www.dovepress.com/comparative-safety-of-intravenous-ferumoxytol-versus-ferric-carboxymal-peer-reviewed-article-JBM

Similar Items